TIMELEAF
HISHIPHAGEN-C INJ
HISHIPHAGEN-C INJ
Normaler Preis
$211.00 USD
Normaler Preis
Verkaufspreis
$211.00 USD
Grundpreis
pro
Verfügbarkeit für Abholungen konnte nicht geladen werden
HISHIPHAGEN-C INJ (히시파겐씨 주) is an injectable prescription medication imported from Japan (by Nipro Pharma), marketed by GC Wellbeing (Green Cross) in Korea. It's primarily used as a liver‑function enhancer and an adjuvant therapy for certain allergic skin conditions and drug-related toxicities
Composition
- Mono‑ammonium glycyrrhizinate (glycyrrhizin derivative): 53 mg per mL (equivalent to ~40 mg glycyrrhizic acid)
- L‑cysteine hydrochloride: 20 mg per mL
- Glycine: 400 mg per mL
The Pack includes
50 ampules
Benefits
- Liver support: Improves liver enzyme levels in chronic hepatitis and cirrhosis patients, potentially lowering disease progression
- Detoxification: L‑cysteine and glycine aid in metabolizing toxins and drugs
- Anti‑inflammatory & immune‑modulating: Effective as an adjunct in urticaria, eczema, allergic dermatoses, and drug-induced skin reactions
- Fatigue and hangover relief: Often known as the “licorice shot,” it’s popularly used for general fatigue and hangover recovery .
Pharmacodynamics
- Mono‑ammonium glycyrrhizinate converts to glycyrrhetinic acid, inhibiting 11β‑hydroxysteroid dehydrogenase type 2, enhancing cortisol activity and producing anti‑inflammatory effects.
- L‑cysteine and glycine serve as antioxidants and support hepatic detoxification
Dosage & Administration
- Adults: Intravenous injection of 2–20 mL once daily.
- For chronic liver disease: 40–60 mL IV once daily, not to exceed 100 mL/day.
- Adjust according to age, symptoms, and severity. Administered via IV bolus or drip
Duration
- Treatment duration varies based on clinical response and liver enzyme normalization.
- Typically administered once daily over days or weeks, tailored per disease severity and monitoring.
